{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:09:39Z","timestamp":1778818179007,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Hospitals Authority Youth Programme","award":["QML-20230516"],"award-info":[{"award-number":["QML-20230516"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272168"],"award-info":[{"award-number":["82272168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-03170-w","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T03:59:02Z","timestamp":1735271942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development and validation of a radiomics nomogram for preoperative prediction of BRAFV600E mutation status in adult patients with craniopharyngioma"],"prefix":"10.1007","volume":"48","author":[{"given":"Ning","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kefan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songbai","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"1","key":"3170_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"HL M\u00fcller","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Prim 5(1):75. https:\/\/doi.org\/10.1038\/s41572-019-0125-9","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"3170_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3171\/2023.5.Jns222791","volume":"140","author":"N Qiao","year":"2024","unstructured":"Qiao N, Li C, Liu F et al (2024) Risk factors for cerebrospinal fluid leak after extended endoscopic endonasal surgery for adult patients with craniopharyngiomas: a multivariate analysis of 364 cases. J Neurosurg 140(1):47\u201358. https:\/\/doi.org\/10.3171\/2023.5.Jns222791","journal-title":"J Neurosurg"},{"issue":"6","key":"3170_CR3","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2016.9.Focus16325","volume":"41","author":"JC Martinez-Gutierrez","year":"2016","unstructured":"Martinez-Gutierrez JC, D\u2019Andrea MR, Cahill DP, Santagata S, Barker FG 2nd, Brastianos PK (2016) Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy. Neurosurg Focus 41(6):E2. https:\/\/doi.org\/10.3171\/2016.9.Focus16325","journal-title":"Neurosurg Focus"},{"issue":"3","key":"3170_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/brainsci13030515","volume":"13","author":"G Jannelli","year":"2023","unstructured":"Jannelli G, Calvanese F, Paun L, Raverot G, Jouanneau E (2023) Current advances in papillary craniopharyngioma: State-of-the-art therapies and overview of the literature. Brain Sci 13(3):515. https:\/\/doi.org\/10.3390\/brainsci13030515","journal-title":"Brain Sci"},{"issue":"1","key":"3170_CR5","doi-asserted-by":"publisher","first-page":"Cns106","DOI":"10.2217\/cns-2023-0018","volume":"13","author":"N Yu","year":"2024","unstructured":"Yu N, Raslan OA, Lee HS et al (2024) Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review. CNS Oncol 13(1):Cns106. https:\/\/doi.org\/10.2217\/cns-2023-0018","journal-title":"CNS Oncol"},{"key":"3170_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02382-7","author":"M Losa","year":"2024","unstructured":"Losa M, Mazza E, Pedone E et al (2024) Targeted therapy in BRAF mutated aggressive papillary craniopharyngioma: a case report and overview of the literature. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02382-7","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"3170_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/ijms25020723","volume":"25","author":"E Agosti","year":"2024","unstructured":"Agosti E, Zeppieri M, Antonietti S et al (2024) Advancing craniopharyngioma management: A systematic review of current targeted therapies and future perspectives. Int J Mol Sci 25(2):723. https:\/\/doi.org\/10.3390\/ijms25020723","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3170_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa2213329","volume":"389","author":"PK Brastianos","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S et al (2023) BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389(2):118\u2013126. https:\/\/doi.org\/10.1056\/NEJMoa2213329","journal-title":"N Engl J Med"},{"key":"3170_CR9","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.wneu.2023.08.137","volume":"180","author":"ZP Wu","year":"2023","unstructured":"Wu ZP, Wang YL, Wang LC et al (2023) Case report: Successful use of BRAF\/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma. World Neurosurg 180:e117\u2013e126. https:\/\/doi.org\/10.1016\/j.wneu.2023.08.137","journal-title":"World Neurosurg"},{"key":"3170_CR10","doi-asserted-by":"publisher","first-page":"882381","DOI":"10.3389\/fendo.2022.882381","volume":"13","author":"F Calvanese","year":"2022","unstructured":"Calvanese F, Jacquesson T, Manet R et al (2022) Neoadjuvant B-RAF and MEK inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm. Front Endocrinol 13:882381. https:\/\/doi.org\/10.3389\/fendo.2022.882381","journal-title":"Front Endocrinol"},{"issue":"6","key":"3170_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/jcpt.13600","volume":"47","author":"PE Nussbaum","year":"2022","unstructured":"Nussbaum PE, Nussbaum LA, Torok CM, Patel PD, Yesavage TA, Nussbaum ES (2022) Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift. J Clin Pharm Ther 47(6):826\u2013831. https:\/\/doi.org\/10.1111\/jcpt.13600","journal-title":"J Clin Pharm Ther"},{"key":"3170_CR12","doi-asserted-by":"publisher","first-page":"652005","DOI":"10.3389\/fmed.2021.652005","volume":"8","author":"M Fasano","year":"2021","unstructured":"Fasano M, Della Corte CM, Caterino M et al (2021) Dramatic therapeutic response to dabrafenib plus trametinib in BRAF V600E mutated papillary craniopharyngiomas: a case report and literature review. Front Med 8:652005. https:\/\/doi.org\/10.3389\/fmed.2021.652005","journal-title":"Front Med"},{"issue":"1","key":"3170_CR13","doi-asserted-by":"publisher","first-page":"vdaa141","DOI":"10.1093\/noajnl\/vdaa141","volume":"2","author":"AL Di Stefano","year":"2020","unstructured":"Di Stefano AL, Guyon D, Sejean K et al (2020) Medical debulking with BRAF\/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma. Neuro-Oncol Adv 2(1):vdaa141. https:\/\/doi.org\/10.1093\/noajnl\/vdaa141","journal-title":"Neuro-Oncol Adv"},{"issue":"12","key":"3170_CR14","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.6004\/jnccn.2020.7624","volume":"18","author":"K Khaddour","year":"2020","unstructured":"Khaddour K, Chicoine MR, Huang J, Dahiya S, Ansstas G (2020) Successful Use of BRAF\/MEK Inhibitors as a Neoadjuvant Approach in the Definitive Treatment of Papillary Craniopharyngioma. J Natl Compr Cancer Netw: JNCCN 18(12):1590\u20131595. https:\/\/doi.org\/10.6004\/jnccn.2020.7624","journal-title":"J Natl Compr Cancer Netw: JNCCN"},{"issue":"6","key":"3170_CR15","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3171\/2019.8.Jns19643","volume":"133","author":"A Bernstein","year":"2019","unstructured":"Bernstein A, Mrowczynski OD, Greene A et al (2019) Dual BRAF\/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity. J Neurosurg 133(6):1704\u20131709. https:\/\/doi.org\/10.3171\/2019.8.Jns19643","journal-title":"J Neurosurg"},{"issue":"4","key":"3170_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3171\/2017.11.Jns172373","volume":"130","author":"BT Himes","year":"2018","unstructured":"Himes BT, Ruff MW, Van Gompel JJ et al (2018) Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report. J Neurosurg 130(4):1299\u20131303. https:\/\/doi.org\/10.3171\/2017.11.Jns172373","journal-title":"J Neurosurg"},{"issue":"5","key":"3170_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11102-015-0663-4","volume":"19","author":"SJ Aylwin","year":"2016","unstructured":"Aylwin SJ, Bodi I, Beaney R (2016) Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary 19(5):544\u2013546. https:\/\/doi.org\/10.1007\/s11102-015-0663-4","journal-title":"Pituitary"},{"issue":"2","key":"3170_CR18","doi-asserted-by":"publisher","first-page":"djv310","DOI":"10.1093\/jnci\/djv310","volume":"108","author":"PK Brastianos","year":"2016","unstructured":"Brastianos PK, Shankar GM, Gill CM et al (2016) Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst 108(2):djv310. https:\/\/doi.org\/10.1093\/jnci\/djv310","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3170_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12883-018-1216-z","volume":"19","author":"X Chen","year":"2019","unstructured":"Chen X, Tong Y, Shi Z et al (2019) Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol 19(1):6. https:\/\/doi.org\/10.1186\/s12883-018-1216-z","journal-title":"BMC Neurol"},{"issue":"2","key":"3170_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/neuros\/nyy569","volume":"85","author":"S Fujio","year":"2019","unstructured":"Fujio S, Juratli TA, Arita K et al (2019) A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery 85(2):204\u2013210. https:\/\/doi.org\/10.1093\/neuros\/nyy569","journal-title":"Neurosurgery"},{"issue":"1","key":"3170_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3171\/2017.4.Jns163113","volume":"129","author":"Q Yue","year":"2018","unstructured":"Yue Q, Yu Y, Shi Z et al (2018) Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features. J Neurosurg 129(1):27\u201334. https:\/\/doi.org\/10.3171\/2017.4.Jns163113","journal-title":"J Neurosurg"},{"issue":"8","key":"3170_CR22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/neuonc\/noab294","volume":"24","author":"AK Mei\u00dfner","year":"2022","unstructured":"Mei\u00dfner AK, Gutsche R, Galldiks N et al (2022) Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases. Neuro Oncol 24(8):1331\u20131340. https:\/\/doi.org\/10.1093\/neuonc\/noab294","journal-title":"Neuro Oncol"},{"key":"3170_CR23","doi-asserted-by":"publisher","first-page":"599888","DOI":"10.3389\/fonc.2020.599888","volume":"10","author":"G Ma","year":"2020","unstructured":"Ma G, Kang J, Qiao N et al (2020) Non-invasive radiomics approach predict invasiveness of adamantinomatous craniopharyngioma before surgery. Front Oncol 10:599888. https:\/\/doi.org\/10.3389\/fonc.2020.599888","journal-title":"Front Oncol"},{"issue":"5","key":"3170_CR24","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/jmri.27761","volume":"54","author":"ZS Huang","year":"2021","unstructured":"Huang ZS, Xiao X, Li XD et al (2021) Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma. J Magn Reson Imaging: JMRI 54(5):1541\u20131550. https:\/\/doi.org\/10.1002\/jmri.27761","journal-title":"J Magn Reson Imaging: JMRI"},{"issue":"1","key":"3170_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/jpm12010045","volume":"12","author":"B Chen","year":"2022","unstructured":"Chen B, Chen C, Zhang Y et al (2022) Differentiation between germinoma and craniopharyngioma using radiomics-based machine learning. J Personalized Med 12(1):45. https:\/\/doi.org\/10.3390\/jpm12010045","journal-title":"J Personalized Med"},{"key":"3170_CR26","doi-asserted-by":"publisher","first-page":"709321","DOI":"10.3389\/fonc.2021.709321","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Xiao D, Nie C et al (2021) Development of a nomogram based on preoperative Bi-Parametric MRI and blood indices for the differentiation between cystic-solid pituitary adenoma and craniopharyngioma. Front Oncol 11:709321. https:\/\/doi.org\/10.3389\/fonc.2021.709321","journal-title":"Front Oncol"},{"issue":"6","key":"3170_CR27","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3171\/2020.10.Jns202779","volume":"135","author":"N Qiao","year":"2021","unstructured":"Qiao N, Yang X, Li C et al (2021) The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma. J Neurosurg 135(6):1714\u20131724. https:\/\/doi.org\/10.3171\/2020.10.Jns202779","journal-title":"J Neurosurg"},{"issue":"3","key":"3170_CR28","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X et al (2022) Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. Commentary. iMeta 1(3):e36. https:\/\/doi.org\/10.1002\/imt2.36","journal-title":"iMeta"},{"issue":"Suppl 2","key":"3170_CR29","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.21037\/tcr.2018.10.21","volume":"8","author":"M Giordano","year":"2019","unstructured":"Giordano M, Zaed I (2019) Value of magnetic resonance imaging in predicting BRAF mutation in craniopharyngiomas. Transl Cancer Res 8(Suppl 2):S97-s98. https:\/\/doi.org\/10.21037\/tcr.2018.10.21","journal-title":"Transl Cancer Res"},{"issue":"10","key":"3170_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1159\/000521652","volume":"112","author":"R Prieto","year":"2022","unstructured":"Prieto R, Barrios L, Pascual JM (2022) Papillary craniopharyngioma: A type of tumor primarily impairing the hypothalamus - A comprehensive anatomo-clinical characterization of 350 well-described cases. Neuroendocrinology 112(10):941\u2013965. https:\/\/doi.org\/10.1159\/000521652","journal-title":"Neuroendocrinology"},{"issue":"5","key":"3170_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1227\/01.neu.0000120421.11171.61","volume":"54","author":"J Steno","year":"2004","unstructured":"Steno J, Mal\u00e1cek M, B\u00edzik I (2004) Tumor-third ventricular relationships in supradiaphragmatic craniopharyngiomas: correlation of morphological, magnetic resonance imaging, and operative findings. Neurosurgery. 54(5):1051\u201358. https:\/\/doi.org\/10.1227\/01.neu.0000120421.11171.61. discussion 1058-60","journal-title":"Neurosurgery."}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-03170-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:16:10Z","timestamp":1772079370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-03170-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3170"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-03170-w","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Beijing Tiantan Hospital of Capital Medical University (KY 2021\u2013041-02). The study was conducted according to the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent has been obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have reviewed and approved the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}